natgillin/translations-raw huggingface dataset:
Levitra orodispersible tablets must be taken without liquid and immediately upon release from the blister. 
Zdravilo Levitra orodisperzibilne tablete je treba vzeti brez tekočine, takoj, ko se odpre pretisni omot.
In two interaction studies with healthy normotensive volunteers after forced titration of the alpha-blockers tamsulosin or terazosin to high doses, hypotension (in some cases symptomatic) was reported in a significant number of subjects after co-administration of vardenafil. 
V dveh študijah o medsebojnem delovanju zdravil, v katerih so sodelovali zdravi prostovoljci, ki so imeli normalen krvni tlak, se je po pospešeni titraciji zaviralcev adrenergičnih receptorjev alfa tamsulozina oziroma terazosina do velikih odmerkov pri pomembnem številu preiskovancev po sočasnem zaužitju vardenafila pojavila hipotenzija (ki je bila v nekaterih primerih simptomatska).
Levitra 10 mg orodispersible tablets are not for use in patients with moderate (Child-Pugh B) and severe hepatic impairment (Child-Pugh C; see section 4.3). 
Zdravilo Levitra 10 mg orodisperzibilne tablete ni indicirano pri bolnikih z zmerno (Child-Pugh B) in hudo jetrno okvaro (Child-Pugh C; glejte poglavje 4.3).
In a specific study, where vardenafil (20 mg) was co-administered with slow release nifedipine (30 mg or 60 mg) in hypertensive patients, there was an additional reduction on supine systolic blood pressure of 6 mmHg and supine diastolic blood pressure of 5 mmHg accompanied with an increase in heart rate of 4 bpm. 
V posebni študiji, v kateri so bolniki s hipertenzijo jemali vardenafil (20 mg) sočasno z nifedipinom v obliki s počasnim sproščanjem (30 mg ali 60 mg), se jim je sistolični krvni tlak leže dodatno znižal za 6 mmHg, diastolični za 5 mmHg, srčna frekvenca pa se je zvečala za 4 utripe na minuto.
The response rates for the ability to obtain and maintain an erection were 76% and 59% on vardenafil compared to 41% and 22% on placebo for patients who completed three months treatment which were clinically and statistically significant (p<0.001). 
Po tromesečnem zdravljenju je bila odzivnost bolnikov glede zmožnosti doseganja in ohranjanja erekcije 76- oz. 59-odstotna pri bolnikih, ki so jemali vardenafil, ter 41- oz. 22-odstotna pri tistih, ki so dobivali placebo, kar je bilo klinično in statistično pomembno (p < 0,001).
How to take Levitra 
Kako jemati zdravilo Levitra
Men who take too much Levitra may experience more side effects or may get severe back pain. 
Če ste vzeli večji odmerek zdravila Levitra, kot bi smeli Pri moških, ki so vzeli večji odmerek, se lahko pojavi več neželenih učinkov ali pa hude bolečine v križu.
Concomitant use of vardenafil with HIV protease inhibitors such as ritonavir and indinavir is contraindicated, as they are very potent inhibitors of CYP3A4 (see section 4.5). 
Sočasna uporaba vardenafila in zaviralcev HIV-proteaze, kot sta ritonavir in indinavir, je kontraindicirana, ker sta zelo močna zaviralca CYP3A4 (glejte poglavje 4.5).
The pharmacokinetics of vardenafil in patients with severely impaired hepatic function (Child-Pugh C) has not been studied (see section 4.3). 
Farmakokinetika vardenafila pri bolnikih s hudo jetrno okvaro (Child-Pugh C) ni raziskana (glejte poglavje 4.3).
However, there is no information on the possible potentiation of the hypotensive effects of nitrates by vardenafil in patients, and concomitant use of Levitra orodispersible tablets and nitrates is therefore contraindicated (see section 4.3). 
Ni pa podatkov o tem, ali vardenafil zveča hipotenzijski učinek nitratov, zato je sočasna uporaba zdravila Levitra orodisperzibilne tablete in nitratov kontraindicirana (glejte poglavje 4.3).
The adverse reactions reported with Levitra film-coated tablets or 10 mg orodispersible tablets in clinical trials were generally transient and mild to moderate in nature. 
Neželeni učinki o katerih so poročali v kliničnih preskušanjih pri uporabi zdravila Levitra filmsko obložene tablete ali Levitra 10 mg orodisperzibilne tablete so bili v glavnem prehodni in blagi do zmerni.
Please tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription. 
Druga zdravila in zdravilo Levitra Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
Therefore, concomitant treatment should be initiated only if the patient is stable on his alpha-blocker therapy. 
Sočasno zdravljenje z vardenafilom se lahko začne samo, če je bolnikovo zdravstveno stanje pri zdravljenju z zaviralcem adrenergičnih receptorjev alfa stabilno.
Levitra 10 mg orodispersible tablets are round and white. 
Zdravilo Levitra 10 mg orodisperzibilne tablete so okrogle, bele tablete.
No dose adjustment is required in patients with mild to moderate renal impairment. 
Bolnikom z blago do zmerno ledvično okvaro odmerka ni treba prilagajati.
Hypotension was not observed when vardenafil 5 mg and terazosin administration was separated by 6 hours. 
Ta se ni pojavila, če je od zaužitja 5 mg vardenafila do zaužitja terazosina minilo šest ur.
The vardenafil results showed an increase in QTc (Fridericia) of 8 msec (90% CI: 6-9) and 10 msec (90% CI: 8-11) at 10 and 80 mg doses compared to placebo and an increase in QTci of 4 msec (90% CI: 3-6) and 6 msec (90% CI: 4-7) at 10 and 80 mg doses compared to placebo, at one hour post-dose. 
Raziskovalci so ugotovili, da se eno uro po zaužitju 10- ali 80miligramskega odmerka vardenafila QTc (Fridericia) zveča za 8 msec (90-odstotni interval zaupanja: 6-9) in 10 msec (90-odstotni interval zaupanja: 8-11) v primerjavi s placebom, QTci za 4 msec (90odstotni interval zaupanja: 3-6) in 6 msec (90-odstotni interval zaupanja: 4-7).
This medicine contains 1.80 mg aspartame in each 10 mg orodispersible tablet. 
To zdravilo vsebuje 1,80 mg aspartama v vsaki 10-mg orodisperzibilni tableti.
Patients with mild hepatic impairment should start treatment with Levitra 5 mg film-coated tablets. 
Bolniki z blago jetrno okvaro morajo zdravljenje začeti z zdravilom Levitra 5 mg filmsko obložene tablete.
No clinical trials in CNS diseases (except spinal cord injury), patients with severe renal or hepatic impairment, pelvic surgery (except nerve-sparing prostatectomy) or trauma or radiotherapy and hypoactive sexual desire or penile anatomic deformities have been performed. 
V preskušanja niso bili vključeni bolniki z boleznimi osrednjega živčevja (razen bolniki s poškodbo hrbtenjače), hudimi motnjami pri delovanju ledvic ali jeter, bolniki, ki so imeli poškodbo, kirurški poseg v medenici (razen odstranitve prostate z ohranitvijo živcev), bolniki na radioterapiji in bolniki z zmanjšanim spolnim poželenjem ali anatomskimi deformacijami penisa.
It reduces the action of the natural chemical in your body which makes erections go away. 
Zdravilo Levitra zavira delovanje naravne kemične spojine v vašem telesu, ki povzroči uplahnitev penisa.
Cases of sudden death, fast or altered heart beat, heart attack, chest pain, and trouble in cerebral circulation (including temporarily decreased blood flow to parts of the brain and bleeding in the brain) have been reported in men taking vardenafil. 
Pri moških, ki so jemali vardenafil, so poročali o primerih nenadne smrti, hitrem ali spremenjenem srčnem utripu, srčnem napadu, bolečinah v prsnem košu in motnjah v možganskem krvnem obtoku (vključno z začasno zmanjšanim pretokom krvi v določenih delih možganov in krvavitvi v možganih).
Nicorandil is a hybrid of potassium channel opener and nitrate. 
Nikorandil je mešanec aktivatorja kalijevih kanalčkov in nitrata.
The ability to maintain the erection (SEP 3) in this broad ED population was given as 53% (5 mg), 63% (10 mg) and 65% (20 mg) compared to 29% on placebo. 
Zmožnost ohranjanja erekcije (SEP 3) v tej širši populaciji moških z ED je bila 53-odstotna (5 mg), 63- (10 mg) in 65-odstotna (20 mg) pri bolnikih, ki so jemali vardenafil, in 29-odstotna pri tistih, ki so dobivali placebo.
Therefore the orodispersible formulation should not be used as an equivalent to vardenafil 10 mg film-coated tablets. 
Orodisperzibilnih tablet se zato ne sme uporabljati kot ekvivalent filmsko obloženim tabletam po 10 mg vardenafila.
Mean vardenafil AUC was increased by 21 to 29% (middle aged and elderly ED patients) or 44% (young healthy subjects) with 10 mg orodispersible tablets compared to film-coated tablets as a result of local oral absorption of a small amount of drug in the oral cavity. 
Povprečna vrednost AUC za vardenafil je povečana za 21 do 29 % (pri bolnikih v srednjih letih ali starejših bolnikih z erektilno disfunkcijo) ali 44 % (pri mlajših bolnikih), pri bolnikih, ki jemljejo 10-miligramske orodisperzibilne tablete v primerjavi z jemanjem filmsko obloženih tablet.
Vardenafil pharmacokinetics has not been studied in patients requiring dialysis (see section 4.3). 
Farmakokinetika vardenafila ni raziskana pri bolnikih na dializi (glejte poglavje 4.3).
- Medicine for the treatment of arrhythmias, such as quinidine, procainamide, amiodarone or sotalol. 
- zdravila za zdravljenje aritmij, npr. kinidin, prokainamid, amiodaron ali sotalol, - ritonavir ali indinavir - zdravili za HIV.
The co-administration of PDE5 inhibitors, including vardenafil, with guanylate cyclase stimulators, such as riociguat, is contraindicated as it may potentially lead to symptomatic hypotension (see section 
Sočasna uporaba zaviralcev PDE5, vključno z vardenafilom, s stimulatorji gvanilat-ciklaze, kot je riociguat, je kontraindicirana, saj lahko privede do simptomatske hipotenzije (glejte poglavje 4.5).
Vardenafil in film-coated tablets is metabolised predominantly by hepatic metabolism via cytochrome P450 (CYP) isoform 3A4 with some contribution from CYP3A5 and CYP2C isoforms. 
Vardenafil iz filmsko obloženih tablet se presnavlja predvsem v jetrih s pomočjo citokroma P450 (CYP), izooblike 3A4, pri čemer nekoliko prispevata tudi izoobliki CYP3A5 in CYP2C.
Grapefruit juice being a weak inhibitor of CYP3A4 gut wall metabolism, may give rise to modest increases in plasma levels of vardenafil (see section 4.4). 
Ker je grenivkin sok šibak zaviralec presnove CYP3A4 v steni prebavil, lahko povzroči rahlo zvišanje plazemske ravni vardenafila (glejte poglavje 4.4).
Film coat: macrogol 400, hypromellose, titanium dioxide (E171), ferric oxide yellow (E172), ferric oxide red (E172). 
filmska obloga: makrogol 400, hipromeloza, titanov dioksid (E171), rumeni železov oksid (E172), rdeči železov oksid (E172).
Bayer SA-NV Tél/Tel: +32-(0)2-535 63 11 
Luxembourg/Luxemburg Bayer SA-NV Tél/Tel: +32-(0)2-535 63 11
The number of patients who returned to a normal IIEF domain score (>26) were 53% on vardenafil compared to 9% on placebo. 
53-odstotkov bolnikov, ki so jemali vardenafil je ponovno imelo normalno erektilno funkcijo (> 26) v primerjavi z 9-odstotki bolnikov, ki so jemali placebo.
• When vardenafil (film-coated tablets) was given at doses of 5, 10 or 20 mg on a background of stable therapy with tamsulosin, there was no symptomatic reduction in blood pressure, although 3/21 tamsulosin treated subjects exhibited transient standing systolic blood pressures of less than 85 mmHg. 
• Pri bolnikih, ki so se zdravili s tamsulozinom in katerih zdravstveno stanje je bilo stabilno, jemanje filmsko obloženih tablet po 5-, 10- ali 20 mg vardenafila ni povzročilo simptomatskega znižanja krvnega tlaka, čeprav je stoje izmerjen sistolični krvni tlak pri treh bolnikih (od 21, ki so se zdravili s tamsulozinom), prehodno znašal manj kot 85 mmHg.
In single dose volunteer studies, doses up to and including 80 mg vardenafil (film-coated tablets) per day were tolerated without exhibiting serious adverse reactions. 
V študiji, v kateri so prostovoljci na dan zaužili en odmerek, manjši ali enak 80 mg vardenafila (filmsko obložene tablete), so ugotovili, da so zdravilo dobro prenašali in niso imeli resnih neželenih učinkov.
Concomitant use of vardenafil with the potent CYP3A4 inhibitors ketoconazole and itraconazole (oral form) is contraindicated in men older than 75 years. 
Sočasna uporaba vardenafila in močnih zaviralcev CYP3A4, kot sta ketokonazol in itrakonazol (za peroralno uporabo), je pri moških, starih več kot 75 let, kontraindicirana.
Serious cardiovascular events including sudden death, tachycardia, myocardial infarction, ventricular tachy-arrythmia, angina pectoris, and cerebrovascular disorders (including transient ischaemic attack and cerebral haemorrhage), have been reported in temporal association with vardenafil. 
V časovni povezavi z uporabo vardenafila so poročali o resnih kardiovaskularnih dogodkih, med drugim o nenadni smrti, tahikardiji, miokardnem infarktu, ventrikularni tahiaritmiji, angini pektoris in cerebrovaskularnih motnjah (vključno z tranzitornim ishemičnim napadom in možgansko krvavitvijo).
The safety of vardenafil has not been studied in the following sub-groups of patients and its use is therefore contraindicated until further information is available: - severe hepatic impairment (Child-Pugh C), - end stage renal disease requiring dialysis, - hypotension (blood pressure <90/50 mmHg), - recent history of stroke or myocardial infarction (within the last 6 months), - unstable angina and known hereditary retinal degenerative disorders such as retinitis pigmentosa. 
Varnost vardenafila ni raziskana v podskupinah bolnikov, - ki imajo hude motnje pri delovanju jeter (Child-Pugh C), - ki imajo končno ledvično odpoved, ki zahteva dializno zdravljenje, - ki imajo hipotenzijo (krvni tlak < 90/50 mmHg), - ki so doživeli možgansko kap ali miokardni infarkt (v zadnjih šestih mesecih), - ki imajo nestabilno angino pektoris in znano dedno degenerativno bolezen mrežnice (retinitis pigmentosa).
In pooled data from the two vardenafil 10 mg orodispersible tablets trials, IIEF-EF domain scores were significantly higher with vardenafil 10 mg orodispersible tablet versus placebo. 
V zbranih podatkih iz dveh kliničnih preskušanj z orodisperzibilnimi tabletami po 10 mg vardenafila, je bila vrednost IIEF-EF pomembno večja pri orodisperzibilnih tabletah po 10 mg vardenafila v primerjavi s placebom.
Tablet core: crospovidone, magnesium stearate, microcrystalline cellulose, colloidal anhydrous silica. 
jedro tablete: krospovidon, magnezijev stearat, mikrokristalna celuloza, brezvoden koloidni silicijev dioksid;
Vardenafil is metabolised predominantly by hepatic enzymes via cytochrome P450 (CYP) isoform 3A4, with some contribution from CYP3A5 and CYP2C isoforms. 
Vardenafil se v glavnem presnavlja s pomočjo jetrnih encimov prek citokroma P450 (CYP), izooblike 3A4; sodelujeta tudi izoobliki CYP3A5 in CYP2C.
In patients with moderate impairment (Child-Pugh B), the mean AUC and Cmax increased by 160% and 133% respectively, compared to healthy control subjects (see section 4.2). 
Pri bolnikih z zmerno jetrno okvaro (Child-Pugh B) sta se povprečni vrednosti AUC in Cmax v primerjavi z zdravimi preiskovanci iz kontrolne skupine zvečali za 160 % oz. 133 % (glejte poglavje 4.2).
Levitra 5 mg film-coated tablets Levitra10 mg film-coated tablets Levitra 20 mg film-coated tablets 
Levitra 5 mg filmsko obložene tablete Levitra 10 mg filmsko obložene tablete Levitra 20 mg filmsko obložene tablete
No significant interactions were shown when warfarin (25 mg), which is metabolised by CYP2C9, or digoxin (0.375 mg) was co-administered with vardenafil (20 mg film-coated tablets). 
Po sočasni uporabi varfarina (25 mg), ki se presnavlja s pomočjo CYP2C9, ali digoksina (0,375 mg) z vardenafilom (20 mg filmsko obložene tablete) se ni pojavila nobena pomembnejša interakcija.
The total body clearance of vardenafil is 56 l/h with a resultant terminal half-life of approximately 4-5 hours. 
Celoten očistek vardenafila iz telesa znaša 56 l/h.
Magnesium stearate, aspartame (E951), peppermint flavour, mannitol (E421), sorbitol (E420), crospovidone and silica colloidal hydrated. 
- Druge sestavine zdravila so: magnezijev stearat, aspartam (E951), aroma poprove mete, manitol (E421), sorbitol (E420), krospovidon in hidratirani koloidni silicijev dioksid.
In patients with severe renal impairment (creatinine clearance <30 ml/min) a starting dose of Levitra 5 mg film-coated tablets should be considered. 
Začetni odmerek za bolnike s hudo ledvično okvaro (kreatininski očistek < 30 ml/min) je zdravilo Levitra 5 mg filmsko obložene tablete.
Hypotension Hypertension 
Žilne bolezni rdečica hipertenzija hipotenzija
The maximum dose recommended in patients with moderate hepatic impairment (Child-Pugh B) is 10 mg (see sections 4.3 and 5.2). 
Največji priporočen odmerek za bolnike z zmerno jetrno okvaro (Child-Pugh B) je 10 mg (glejte poglavji 4.3 in
In the predefined subgroups 57% (elderly patients), 56% (patients with history of diabetes mellitus), 59% (patients with history of dyslipidemia) and 60% (patients with history of hypertension) of all reported attempts with vardenafil 10 mg orodispersible tablets were successful in terms of maintenance of erection. 
V predhodno opredeljenih podskupinah bolnikov, ki so dobivali orodisperzibilne tablete po 10 mg vardenafila, so pri 57 % (starejši bolniki), 56 % (bolniki za anamnezo sladkorne bolezni), 59 % (bolniki z anamnezo displipidemije) in 60 % (bolniki z anamnezo hipertenzije) poročali, da je bilo občevanje uspešno; bolniki so ohranili erekcijo.
There is no relevant indication for use of Levitra in children. 
Ustreznih indikacij za uporabo zdravila Levitra pri otrocih in mladostnikih ni.
The concomitant use of alpha-blockers and vardenafil may lead to symptomatic hypotension in some patients because both are vasodilators. 
Sočasna uporaba zaviralcev adrenergičnih receptorjev alfa Sočasna uporaba zaviralcev adrenergičnih receptorjev alfa in vardenafila lahko pri nekaterih bolnikih povzroči simptomatsko hipotenzijo, kajti tako prvi kot drugi spadajo med vazodilatatorje.
Across the pivotal trials, treatment with vardenafil (film-coated tablets) resulted in an improvement of erectile function compared to placebo. 
V vseh najpomembnejših preskušanjih se je med zdravljenjem z vardenafilom (filmsko obloženimi tabletami), v primerjavi s placebom, erektilna funkcija izboljšala.
Therefore, the current information of section 4.8 should be revised to highlight the temporal association with vardenafil. 
Da bi poudarili časovno povezanost z vardenafilom, je treba posodobiti poglavje 4.8 v informacijah o zdravilu.
Cimetidine (400 mg twice daily), a non-specific cytochrome P450 inhibitor, had no effect on vardenafil AUC and Cmax when co-administered with vardenafil (20 mg) to healthy volunteers. 
Cimetidin (400 mg dvakrat na dan), ki je nespecifičen zaviralec citokroma P450, pri zdravih prostovoljcih med hkratno uporabo vardenafila (20 mg) ni vplival na vrednost AUC vardenafila in Cmax.
However, an increase to a maximum dose of Levitra 20 mg film-coated tablets should be carefully considered depending on the individual tolerability (see sections 4.4 and 4.8). 
Pri povečanju odmerka na največji odmerek zdravila Levitra 20 mg filmsko obložene tablete je potrebna previdnost; pri tem je treba upoštevati dejstvo, kako ga bolnik prenaša (glejte poglavji 4.4 in 4.8).
A medical history and physical examination should be undertaken to diagnose erectile dysfunction and determine potential underlying causes, before pharmacological treatment is considered. 
Pred začetkom zdravljenja z zdravili je treba pri določanju diagnoze erektilna disfunkcija in vzrokov zanjo, preučiti bolnikovo anamnezo in pregledati bolnika.
It may be risky for you to have sex. - If you suffer from irregular heart beat (cardiac arrhythmia) or inherited heart diseases affecting your electrocardiogram. 
Bodite posebno pozorni pri uporabi zdravila Levitra - če imate težave s srcem; spolni odnosi so za vas lahko tvegani, - če imate motnje srčnega ritma (srčno aritmijo) ali prirojene srčne bolezni, ki vplivajo na elektrokardiogram,
However, there is no information on the possible potentiation of the hypotensive effects of nitrates by vardenafil in patients, and concomitant use is therefore contraindicated (see section 4.3). 
Ni pa podatkov o tem, ali vardenafil zveča hipotenzijski učinek nitratov, zato je sočasna uporaba kontraindicirana (glejte poglavje 4.3).
Vardenafil 20 mg film-coated tablets potentiated the blood pressure lowering effect of sublingual nitroglycerin (0.4 mg) taken 1 and 4 hours after vardenafil administration to healthy middle aged subjects. 
Toda 20-miligramski odmerek vardenafila v filmsko obloženih tabletah je zvečal vpliv nitroglicerina (0,4 mg, sublingvalno) na znižanje krvnega tlaka, ki so ga zdravi moški srednjih let vzeli eno in štiri ure po zaužitju vardenafila.
Back pain Increase in creatine phosphokinase Myalgia Increased muscle tone and cramping 
Bolezni mišičnoskeletnega sistema in vezivnega tkiva bolečine v hrbtu povečane vrednosti kreatinfosfokinaze mialgija povečan mišični tonus in krči
The safety and efficacy of combinations of Levitra orodispersible tablets with Levitra film-coated tablets or other treatments for erectile dysfunction have not been studied. 
Študij o varnosti in učinkovitosti zdravljenja z zdravilom Levitra orodisperzibilne tablete v kombinaciji z zdravilom Levitra filmsko obložene tablete ali drugimi zdravili za erektilno disfunkcijo niso izvedli.
Both vardenafil and sildenafil showed an increase of Fridericia QTc effect of 4 msec (vardenafil) and 5 msec (sildenafil) when compared to either drug alone. 
Pri obeh kombinacijah, z vardenafilom in sildenafilom, se je doba QTc (Fridericia) podaljšala; za 4 msec pri vardenafilu in 5 msec pri sildenafilu v primerjavi s posameznim zdravilom.
In fixed dose studies (film-coated tablets) in a broad population of men with erectile dysfunction, 68% (5 mg), 76% (10 mg) and 80% (20 mg) of patients experienced successful penetrations (SEP 2) compared to 49% on placebo over a three month study period. 
V trimesečnih preskušanjih pri širši populaciji moških z erektilno disfunkcijo, ki so dobivali vedno enak odmerek (filmsko obložene tablete), je bila penetracija uspešna pri 68 % (5 mg), 76 % (10 mg) in 80 % (20 mg) bolnikov (SEP 2), ki so jemali vardenafil, ter pri 49 % bolnikov, ki so dobivali placebo.
Other medicines and Levitra 
Shranjevanje zdravila Levitra
(≥65 years old) (see sections 4.2 and 4.8). 
(glejte poglavji 4.3 in 4.4).
- Don't drink grapefruit juice when you use Levitra. 
- Ko jemljete zdravilo Levitra, ne pijte grenivkinega soka, ker lahko vpliva na učinek zdravila.
The safety and efficacy of combinations of Levitra film-coated tablets with Levitra orodispersible tablets or other treatments for erectile dysfunction have not been studied. 
Študij o varnosti in učinkovitosti zdravljenja z zdravilom Levitra filmsko obložene tablete v kombinaciji z zdravilom Levitra orodisperzibilne tablete ali drugimi zdravili za erektilno disfunkcijo niso izvedli.
- Aspartame: This medicine contains 1.80 mg aspartame in each 10 mg orodispersible tablet. 
- Aspartam: To zdravilo vsebuje 1,80 mg aspartama v vsaki 10-mg orodisperzibilni tableti.
Sorbitol This medicine contains 7.96 mg sorbitol in each 10 mg orodispersible tablet. 
To zdravilo vsebuje 7,96 mg sorbitola v vsaki 10-mg orodisperzibilni tableti.
Effects of vardenafil on other medicinal products 
Učinki vardenafila na druga zdravila
Infection and infestations 
Infekcije in parazitske bolezni konjunktivitis
The CHMP recommends that the terms of the marketing authorisation(s) should be varied. 
Skupina CMDh je sprejela stališče, da je potrebna sprememba dovoljenja (dovoljenj) za promet z zdravili, ki so zajeta v to enotno oceno P
Levitra 10 mg orodispersible tablets 
Levitra 10 mg orodisperzibilne tablete
Concomitant use of vardenafil with potent CYP3A4 inhibitors such as itraconazole and ketoconazole (oral use) should be avoided (see sections 4.3 and 4.4). 
Hkratni uporabi vardenafila in močnih zaviralcev CYP3A4, npr. itrakonazola in ketokonazola (za peroralno uporabo), se je treba izogibati (glejte poglavji 4.3 in 4.4).
Central nervous system haemorrhages and cerebrovascular accidents (CVA) have been monitored in the last PSURs. 
V zadnjih PSUR so spremljali krvavitve v osrednjem živčnem sistemu in cerebrovaskularne dogodke.